Preoperative progressive pneumoperitoneum and botulinum toxin type A in patients with large incisional hernia

Hernia ◽  
2017 ◽  
Vol 21 (2) ◽  
pp. 233-243 ◽  
Author(s):  
J. Bueno-Lledó ◽  
A. Torregrosa ◽  
N. Ballester ◽  
O. Carreño ◽  
F. Carbonell ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Incisional Hernia ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Large Incisional Hernia ◽  
Preoperative Progressive Pneumoperitoneum

Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management

Hernia ◽  
2014 ◽  
Vol 18 (5) ◽  
pp. 647-652 ◽  
Author(s):  
T. R. Ibarra-Hurtado ◽  
C. M. Nuño-Guzmán ◽  
A. G. Miranda-Díaz ◽  
R. Troyo-Sanromán ◽  
R. Navarro-Ibarra ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Incisional Hernia ◽  
Abdominal Wall ◽  
Open Abdomen ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Lateral Abdominal Wall

scholarly journals Complex Incisional Hernia – Easy To Diagnose But What To Do After?

2021 ◽  
pp. 254
Author(s):  
Keyword(s):  
Botulinum Toxin ◽  
Abdominal Wall ◽  
Rapid Development ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Fascial Closure ◽  
Loss Of Domain ◽  
Umbilical Hernia Repair ◽  
Preoperative Progressive Pneumoperitoneum

Introduction. Loss of domain represents a defect in abdominal wall or loss of continuity of fascial closure, with more than 20% of the peritoneal cavity content under the skin in a serous sac, where the reconstruction involves additional reconstructive techniques. Clinical Case. A 63-year-old active smoker with multiple comorbidities such as COPD severe form with the need for oxygen at home (may be an absolute contraindication) and surgical history of open umbilical hernia repair with a rapid development of loss of domain hernia (2 weeks after surgery) was prepared preoperatively with Botulinum Toxin type A and Preoperative Progressive Pneumoperitoneum. Discussion. Despite comorbidities, by optimizing the abdominal wall with Botulinum Toxin type A and Preoperative Progressive Pneumoperitoneum with the intraoperative use of the Rives-Stoppa technique or posterior separation of components, Abdominal Wall Strength Score improves significantly in a short time, with quick socio-economic reintegration and low-rate of complications. Conclusions. By preoperative preparation, with augmentation techniques of the abdominal wall, thus, even the barriers given by comorbidities (absolute contraindications) are overcame, with low postoperative risks, offering the patient a normal quality of life.

scholarly journals Preoperative Progressive Pneumoperitoneum and Botulinum Toxin Type A in Patients With Large Parastomal Hernia

2021 ◽  
Vol 8 ◽  
Author(s):  
Fu-Xin Tang ◽  
Ning Ma ◽  
Xing-Xing Xie ◽  
Shuang Chen ◽  
Zhen Zong ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Parastomal Hernia ◽  
Botulinum Toxin Type A ◽  
Abdominal Cavity ◽  
Muscle Length ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Abdominal Muscle ◽  
Preoperative Progressive Pneumoperitoneum ◽  
The Mean

Background: The combination of preoperative progressive pneumoperitoneum (PPP) and botulinum toxin type A (BTA) in adjuvant treatment of large parastomal hernia (LPH) has not been reported in the previous literature.Methods: From February 2018 to June 2019, 16 patients were diagnosed with LPH in our hospital were included in this study. All patients received PPP and BTA treatment to expand abdominal volume and extend abdominal muscle before surgery. The laparoscopic Sugarbaker method was preferred for defect close.Results: Before and after PPP and BTA, the mean volume of the parastomal hernia (VPH) was 1,522 and 1,644 cc, respectively (P < 0.01), and the mean volume of the abdominal cavity (VAC) was 5,847 and 9,408 cc, respectively (P < 0.01). The VPH/VAC ratio was decreased by an average of 8.4% after the combination management. And the lateral abdominal muscle length was increased by an average of 4.8 cm/side (P < 0.01). These patients underwent surgery successfully, and no hernia recurrence after (17.6 ± 2.4) months of follow-up.Conclusions: The combination of PPP and BTA effectively expand the abdominal volume, decrease the risk of abdominal compartment syndrome (ACS) postoperatively, and beneficial to laparoscopic repair of LPH.

Hip development in children with cerebral palsy and adductor spasticity treated with botulinum toxin type A: A two-year follow-up

2008 ◽  
Vol 39 (05) ◽  
Author(s):  
NH Jung ◽  
F Heinen ◽  
A Reissig ◽  
B Westhoff ◽  
S Berweck ◽  
...  
Keyword(s):  
Cerebral Palsy ◽  
Botulinum Toxin ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Children With Cerebral Palsy

Botulinum Toxin Type A Therapy in Chronic Headache Patients

2005 ◽  
Vol 18 (1) ◽  
pp. 29
Author(s):  
Dong Eon Moon ◽  
Young Eun Moon ◽  
Shi Hyeon Kim ◽  
Eun Sung Kim
Keyword(s):  
Botulinum Toxin ◽  
Chronic Headache ◽  
Botulinum Toxin Type A ◽  
Type A ◽  
Botulinum Toxin Type ◽  
Headache Patients
Sign in / Sign up

Export Citation Format

Share Document